TrialAssure Establishes Presence in The Netherlands to Advance Clinical Trial Transparency, Data Sharing Across Europe

TrialAssure, a leading technology provider advancing clinical trial transparency, disclosure, and data sharing, announced today the opening of TrialAssure B.V., its new European office located in ...

Insurance data can help fill gaps between longer medical trials for patients up against the clock

Randomized clinical trials remain the gold standard for establishing a medication's effects, producing the evidence by which ...

N-Power Medicine and AdventHealth Collaborate to Expand Access to Cancer Care and Research

Power Medicine, a company revolutionizing oncology drug development, and AdventHealth, a faith-based health system focused on whole-person care, today announced a strategic collaboration to make ...

BioVie Completes Enrollment in Phase 2 SUNRISE-PD Trial in Early Parkinson’s Disease

Patient-centric trial aiming to evaluate whether bezisterim can help delay disease progression reaches enrollment milestone -- Topline Results ...
Pancreatic Cancer Action Network

Questions About Clinical Trials? The PanCAN Patient Services Team Can Help

The PanCAN Patient Services team is here for patients and their loved ones as they navigate clinical trials. Our Case Managers offer personal, one-to-one support at every step of the search and ...
Nature

Analysis of phase II and phase III clinical trial terminations from 2013 to 2023

Success rates in phase II and phase III clinical trials are recognized as two of the most powerful drivers of overall efficiency in drug development (Nat. Rev. Drug Disc. 23, 656–657; 2024). With the ...